Xintao Tu

5PUBLICATIONS
10CO-AUTHORS
Liquid biopsiesMolecular targetsInstrumental methods (excl. immunological and bioassay methods)Biologically active moleculesPowder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 24, 2026
Targeting LRRC15-expressing fibroblasts holds therapeutic potential to ameliorate inflammation and fibrosis in autoimmune diseases.

|May 06, 2025
Targeting Innate Immune Checkpoint TREX1 Is a Safe and Effective Immunotherapeutic Strategy in Cancer.

Cong Xing, Xintao Tu, Wanwan Huai

|Nov 15, 2022
Interruption of post-Golgi STING trafficking activates tonic interferon signaling.

Xintao Tu, Ting-Ting Chu, Devon Jeltema

|Jul 22, 2021
Tonic prime-boost of STING signalling mediates Niemann-Pick disease type C.

Ting-Ting Chu, Xintao Tu, Kun Yang

|Jan 15, 2020
Homeostatic regulation of STING protein at the resting state by stabilizer TOLLIP.

Vladislav Pokatayev, Kun Yang, Xintao Tu

Pageof 1

Frequent Collaborators

4 joint publications

Kun Yang

4 joint publications

Nan Yan

2 joint publications

Devon Jeltema

2 joint publications

Kennady Knox